Moral Hazard and Long-Term Care Insurance
道德风险和长期护理保险
基本信息
- 批准号:8212739
- 负责人:
- 金额:$ 29.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAgeAreaAttentionBehaviorBeliefBudgetsCommunitiesDataDisability InsuranceElderlyGovernmentHealthHealth InsuranceHealthcareHome Care ServicesHome Nursing CareHome environmentIncomeIndividualInferiorInsuranceInsurance CarriersInsurance CoverageLiteratureLong-Term CareLong-Term Care InsuranceMarketingMedicaidMethodsMinorityMoralsNatureNursing HomesPoliciesPolicy DevelopmentsPopulationPricePublic PolicyRelative (related person)ResearchResearch PersonnelRetirementRunningServicesSocial WelfareSolutionsSystemWorkbasecommunity based servicecommunity livingconsumer behaviorcostdemographicsdesignevidence baseexhausthazardimprovedpatient home careservice utilizationsimulation
项目摘要
DESCRIPTION (provided by applicant): Recent passage of the Community Living Assistance Services and Supports (CLASS) Act as part of health reform has drawn renewed attention to the long-term care insurance market, a market which has long presented many unanswered questions to researchers and policymakers. Despite the potentially high cost of long-term care and the skewed distribution of those costs, only 10 percent of elderly adults have long-term care insurance, and insurers consequently express greater concern about adverse selection and moral hazard than in typical health insurance markets. While a limited body of research has begun to make progress in understanding long-term care insurance markets and associated behavior, the extent of adverse selection and moral hazard remain largely unknown. Regardless of the eventual fate or form of CLASS, the projected demographics of long-term care use and the associated strain on government budgets point to a more and more urgent need to answer these questions. A particularly under-researched area is that of moral hazard, or the additional use of services that can be attributed to long-term care insurance coverage. Existing research finds little evidence for moral hazard in the case of Medicaid-financed nursing home use, but Medicaid- financed nursing home use may be considered an inferior good. Home health care and privately financed nursing home use may be normal goods and thus more likely to be subject to moral hazard. A broader perspective, including all nursing home use and especially favorable alternatives to nursing homes, such as home care, is required in order to capture fully the extent of moral hazard. Furthermore, recent theoretical work has revisited the common assumption that all moral hazard is welfare-reducing, positing instead that moral hazard attributable to income effects is efficient and welfare-improving while moral hazard attributable to price effects remains inefficient and welfare-reducing. This distinction may be particularly important in long- term care, an area of health care in which public payers currently dominate. In this project, we propose to use a long panel of the Health and Retirement Study to 1) assess the overall extent of moral hazard associated with long-term care insurance coverage, including use of home care; 2) disentangle the estimated moral hazard into efficient moral hazard due to the income effect and inefficient moral hazard due to the price effect, thereby enabling an assessment of the net welfare effect; and 3) conduct policy simulations to aid in appropriate benefit design. Assessing the extent of moral hazard associated with long-term care insurance coverage is essential to financial viability and sustainability of the market, to appropriate benefit design, and to an assessment of the overall welfare effects of a public policy such as CLASS.
PUBLIC HEALTH RELEVANCE: Reasonable solutions to the financing of long-term care have long eluded policymakers and this challenge promises to increase in importance as the population ages. This project proposes to investigate the extent and nature of long-term care utilization in the presence of insurance coverage, research that is essential to financial viability and sustainability of the long-term care insurance market, to appropriate benefit design, and to an assessment of the overall welfare effects of a public policies designed to address long-term care financing.
描述(由申请人提供):最近通过的社区生活援助服务和支持(CLASS)法案作为医疗改革的一部分,重新引起了对长期护理保险市场的关注,这个市场长期以来一直向研究人员和政策制定者提出了许多悬而未决的问题。尽管长期护理的成本可能很高,而且这些成本的分布也不均衡,但只有10%的老年人拥有长期护理保险,因此,保险公司对逆向选择和道德风险的担忧程度高于典型的健康保险市场。虽然有限的研究机构已经开始在理解长期护理保险市场和相关行为方面取得进展,但逆向选择和道德风险的程度在很大程度上仍然未知。无论CLASS的最终命运或形式如何,长期护理使用的预计人口统计数据以及相关的政府预算压力表明,越来越迫切需要回答这些问题。一个特别缺乏研究的领域是道德风险,或可归因于长期护理保险范围的服务的额外使用。现有的研究发现很少有证据表明在医疗补助资助的养老院使用中存在道德风险,但医疗补助资助的养老院使用可能被认为是次品。家庭保健和私人资助的养老院的使用可能是正常商品,因此更容易受到道德风险的影响。为了充分把握道德风险的程度,需要一个更广泛的视角,包括所有养老院的使用,以及特别有利的养老院替代方案,如家庭护理。此外,最近的理论工作重新审视了所有道德风险都是减少福利的普遍假设,取而代之的是假设收入效应导致的道德风险是有效的,并且会改善福利,而价格效应导致的道德风险仍然是低效的,并且会减少福利。这种区别在长期护理中可能尤其重要,长期护理是目前公共支付者占主导地位的卫生保健领域。在这个项目中,我们建议使用健康和退休研究的长小组来1)评估与长期护理保险相关的道德风险的总体程度,包括家庭护理的使用;2)将估计的道德风险分解为由于收入效应而产生的有效道德风险和由于价格效应而产生的无效道德风险,从而能够评估净福利效应;3)进行政策模拟,帮助进行合理的利益设计。评估与长期护理保险覆盖范围相关的道德风险程度,对于市场的财务可行性和可持续性、适当的福利设计以及评估公共政策(如CLASS)的整体福利效果至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RITA TAMARA KONETZKA其他文献
RITA TAMARA KONETZKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RITA TAMARA KONETZKA', 18)}}的其他基金
The Role of Medicaid HCBS in the Post-Acute Period
医疗补助 HCBS 在急性期后的作用
- 批准号:
10095390 - 财政年份:2020
- 资助金额:
$ 29.1万 - 项目类别:
Effects of Care Setting on Persons with Alzheimer's Disease and their Spouses
护理环境对阿尔茨海默病患者及其配偶的影响
- 批准号:
9383443 - 财政年份:2017
- 资助金额:
$ 29.1万 - 项目类别:
Patient Safety in Nursing Homes: A Closer Look at Improvement
疗养院患者安全:仔细观察改进
- 批准号:
9348621 - 财政年份:2016
- 资助金额:
$ 29.1万 - 项目类别:
Patient Safety in Nursing Homes: A Closer Look at Improvement
疗养院患者安全:仔细观察改进
- 批准号:
9219412 - 财政年份:2016
- 资助金额:
$ 29.1万 - 项目类别:
Improving Nursing Home Compare for Dually Eligible Consumers
改善具有双重资格的消费者的疗养院比较
- 批准号:
8450495 - 财政年份:2012
- 资助金额:
$ 29.1万 - 项目类别:
Improving Nursing Home Compare for Dually Eligible Consumers
改善具有双重资格的消费者的疗养院比较
- 批准号:
8723055 - 财政年份:2012
- 资助金额:
$ 29.1万 - 项目类别:
Improving Nursing Home Compare for Dually Eligible Consumers
改善具有双重资格的消费者的疗养院比较
- 批准号:
8550793 - 财政年份:2012
- 资助金额:
$ 29.1万 - 项目类别:
Profitability and Public Reporting: Evidence from Nursing Homes
盈利能力和公共报告:来自疗养院的证据
- 批准号:
8330801 - 财政年份:2011
- 资助金额:
$ 29.1万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.1万 - 项目类别:
Research Grant